The medicinal cannabis producer’s shares have fallen heavily in recent times…
The post Why the Little Green Pharma (ASX:LGP) share price has lost 20% since July appeared first on The Motley Fool Australia. –
The Little Green Pharma Ltd (ASX: LGP) share price has had a tough run over the past few months. This comes despite the medicinal cannabis producer releasing some positive announcements to the market of late.
At Friday’s closing bell, Little Green Pharma shares finished the day down 2.04% to 72 cents apiece. They are now down 22.5% since the start of July
What has Little Green Pharma recently announced?
In late August, Little Green Pharma released its preliminary report for the 2021 financial year, highlighting mixed results.
The company generated more than $7 million in revenue, up 218% over the prior corresponding period. The robust performance came from the sale of medicinal oil and flower products.
On Little Green Pharma’s bottom line, profit after tax came to $24.6 million, an improvement from the $9.3 million loss in FY20. While this appears a sound performance, the $25 million gain on the purchase of the Denmark facility bumped up the end result.
In addition to the result, Little Green Pharma was granted a Schedule 9 licence to supply psilocybin by the Western Australian government. The licence is a key element of the company’s entry into the international field of psychedelic drugs to treat mental illness.
Furthermore, Little Green Pharma successfully imported its first shipment of its THC 16 cannabis flower medicine from its Danish facility into Australia. The Little Green Pharma share price jumped on this news.
Regardless of the positive progress, Little Green Pharma shares have tanked from the beginning of July. Its peers too, Creso Pharma Ltd (ASX: CPH) and Althea Group Holdings Ltd (ASX: AGH) have not been immune. They have fallen 12.5% and 27%, respectively.
A possible catalyst for the fall could be weak investor sentiment as the cannabis sector has been slow to take off. In 2018, there was massive hype in cannabis products, but this has since waned.
About the Little Green Pharma share price
Over the past 12 months, Little Green Pharma shares gradually moved upwards to advance around 150%. The strong accent came off the back of late 2020 where the cannabis sector took off following optimistic investor sentiment.
However, in 2021, the company’s share price moved relatively sideways, registering gains of approximately 30%.
Should you invest $1,000 in Little Green Pharma right now?
Before you consider Little Green Pharma, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Little Green Pharma wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
Here’s why the Alligator Energy (ASX:AGE) share price leapt 113% this past week
The Tinybeans (ASX:TNY) share price has jumped 9% on Friday
West Wits Mining (ASX:WWI) share price surges 23% on project update
Why the Northern Star (ASX:NST) share price sank nearly 3% on Friday
AGL (ASX:AGL) share price falls amid ASA’s planned push for Paris targets
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.